Journey Medical logo
Journey Medical
DERM | NASDAQ
Chart Builder DCF Calculator
$3.70
-$0.63 (-14.55%)
At close: Nov 16, 2026, 4:00 PM ET
$3.80
+$0.10 (+2.70%)
After-hours: Nov 16, 2026, 7:30 PM ET

Journey Medical Company Profile

Company profile explained

Company Profile

Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.

Key Executives

Name Position
Claude Maraoui Founder, President, Chief Executive Officer & Director
Joseph Benesch Chief Financial Officer & Corporate Controller
Ramsey Alloush Chief Operating Officer, General Counsel & Company Secretary
Brian Prout Executive Director of Marketing
Jaclyn Jaffe Senior Director of Corporate Operations
Lindsay Allan Rosenwald Executive Chairman
Louis Donati Director of Market Access
Robert Nevin Chief Commercial Officer

Latest SEC Filings

Date Type Title
Oct 09, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 12, 2026 10-Q Quarterly Report
Aug 12, 2026 8-K Current Report
Jul 31, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 15, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 02, 2026 4 Filing
Jul 02, 2026 4 Filing
Jul 02, 2026 4 Filing
Jun 29, 2026 4 Filing
Jun 26, 2026 4 Filing
View All SEC Filings ➞
Journey Medical
Journey Medical logo
Country United States
IPO Date Nov 12, 2021
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 58
CEO Claude Maraoui

Contact Details

9237 East Via de Ventura Boulevard Scottsdale, Arizona 85258 United States

Stock Details

Ticker Symbol DERM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001867066
CUSIP Number 48115J109
ISIN Number US48115J1097
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.